Clinical Trial Update: A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 trial of ferumoxytol for episodic treatment of iron deficiency anemia in pediatric chronic kidney disease was terminated; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Iron Deficiency Anemia

Drugs mentioned

• FERUMOXYTOL (ferumoxytol)

Snippet

Sponsor: AMAG Pharmaceuticals, Inc. | Conditions: Iron Deficiency Anemia | Phase 3 | Status: TERMINATED | Results posted: 2017-11-06